Related Experiment Videos

Intensive plasma exchange for severe autoimmune hemolytic anemia in a four-month-old infant

L J McCarthy1, C F Danielson, C Fernandez

  • 1Indiana University Medical Center, Indianapolis, Indiana 46202, USA. lmmcarth@iupui.edu

Insights

Intensive plasma exchange (PE) therapy effectively treated autoimmune hemolytic anemia (AIHA) in the smallest infant reported. This approach offers a viable option for severe AIHA cases, even in critically ill neonates.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Critical Care Medicine

Background:

  • Autoimmune hemolytic anemia (AIHA) can be life-threatening in infants.
  • Standard treatments like corticosteroids may be insufficient for severe cases.
  • Plasma exchange (PE) is an extracorporeal therapy that removes autoantibodies.

Observation:

  • A 7.5 kg infant with severe AIHA received intensive PE (52 procedures).
  • The infant experienced complications including cytomegalovirus infection and colon perforation.
  • Specialized protocols were used, including red blood cell priming and fresh frozen plasma substitution.

Findings:

  • The infant achieved complete recovery and remained healthy for over 2 years.
  • PE temporarily reduced autoantibody levels, supporting adjunctive therapy.
  • Close monitoring of calcium levels and specific fluid management were crucial due to the infant's size.

Implications:

  • Intensive PE can be a safe and effective treatment for severe AIHA in very small infants.
  • This case expands the potential application of PE in pediatric hematology.
  • Further research into optimized PE protocols for neonates is warranted.

Related Concept Videos